 Connection
Javier Valle to Risk Assessment
This is a "connection" page, showing publications Javier Valle has written about Risk Assessment.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.684 |
|
|
|
-
Valle JA, Glorioso TJ, Schuetze KB, Grunwald GK, Armstrong EJ, Waldo SW. Contemporary Use of Embolic Protection Devices During Saphenous Vein Graft Intervention. Circ Cardiovasc Interv. 2019 05; 12(5):e007636.
Score: 0.087
-
Brostow DP, Warsavage TJ, Abbate LM, Starosta AJ, Brenner LA, Plomondon ME, Valle JA. Mental illness and obesity among Veterans undergoing percutaneous coronary intervention: Insights from the VA CART program. Clin Obes. 2019 Apr; 9(2):e12300.
Score: 0.086
-
Valle JA, Graham L, Thiruvoipati T, Grunwald G, Armstrong EJ, Maddox TM, Hawn MT, Bradley SM. Facility-level association of preoperative stress testing and postoperative adverse cardiac events. Heart. 2018 12; 104(24):2018-2025.
Score: 0.082
-
Levitan EB, Graham LA, Valle JA, Richman JS, Hollis R, Holcomb CN, Maddox TM, Hawn MT. Pre-operative echocardiography among patients with coronary artery disease in the United States Veterans Affairs healthcare system: A retrospective cohort study. BMC Cardiovasc Disord. 2016 09 05; 16(1):173.
Score: 0.073
-
Armstrong EJ, Graham L, Waldo SW, Valle JA, Maddox TM, Hawn MT. Patient and lesion-specific characteristics predict risk of major adverse cardiovascular events among patients with previous percutaneous coronary intervention undergoing noncardiac surgery. Catheter Cardiovasc Interv. 2017 Mar 01; 89(4):617-627.
Score: 0.072
-
Valle JA, Shetterly S, Maddox TM, Ho PM, Bradley SM, Sandhu A, Magid D, Tsai TT. Postdischarge Bleeding After Percutaneous Coronary Intervention and Subsequent Mortality and Myocardial Infarction: Insights From the HMO Research Network-Stent Registry. Circ Cardiovasc Interv. 2016 06; 9(6).
Score: 0.071
-
Kovach CP, Hebbe A, Glorioso TJ, Barrett C, Bar?n AE, Mavromatis K, Valle JA, Waldo SW. Association of Residual Ischemic Disease With Clinical Outcomes After Percutaneous Coronary Intervention. JACC Cardiovasc Interv. 2022 12 26; 15(24):2475-2486.
Score: 0.028
-
Kovach CP, Hebbe A, Bar?n AE, Strobel A, Plomondon ME, Valle JA, Waldo SW. Clinical Characteristics and Outcomes Among Patients Undergoing High-Risk Percutaneous Coronary Interventions by Single or Multiple Operators: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. J Am Heart Assoc. 2021 12 07; 10(23):e022131.
Score: 0.026
-
Kokkinidis DG, Behan S, Jawaid O, Hossain P, Giannopoulos S, Singh GD, Laird JR, Valle JA, Waldo SW, Armstrong EJ. Laser atherectomy and drug-coated balloons for the treatment of femoropopliteal in-stent restenosis: 2-Year outcomes. Catheter Cardiovasc Interv. 2020 02 15; 95(3):439-446.
Score: 0.023
-
Bricker RS, Glorioso TJ, Jawaid O, Plomondon ME, Valle JA, Armstrong EJ, Waldo SW. Temporal Trends and Site Variation in High-Risk Coronary Intervention and the Use of Mechanical Circulatory Support: Insights From the Veterans Affairs Clinical Assessment Reporting and Tracking (CART) Program. J Am Heart Assoc. 2019 12 17; 8(24):e014906.
Score: 0.023
-
Cantu D, Jawaid O, Kokkinidis D, Giannopoulos S, Valle JA, Waldo SW, Singh GD, Armstrong EJ. Outcomes of Drug-Coated Balloon Angioplasty vs. Conventional Balloon Angioplasty for Endovascular Treatment of Common Femoral Artery Atherosclerotic Disease. Cardiovasc Revasc Med. 2020 07; 21(7):867-874.
Score: 0.023
-
Bricker RS, Valle JA, Plomondon ME, Armstrong EJ, Waldo SW. Causes of Mortality After Percutaneous Coronary Intervention. Circ Cardiovasc Qual Outcomes. 2019 05; 12(5):e005355.
Score: 0.022
-
Armstrong EJ, Graham LA, Waldo SW, Valle JA, Maddox TM, Hawn MT. Incomplete Revascularization Is Associated With an Increased Risk for?Major Adverse Cardiovascular Events?Among Patients Undergoing Noncardiac Surgery. JACC Cardiovasc Interv. 2017 02 27; 10(4):329-338.
Score: 0.019
-
Hollis RH, Holcomb CN, Valle JA, Smith BP, DeRussy AJ, Graham LA, Richman JS, Itani KM, Maddox TM, Hawn MT. Coronary angiography and failure to rescue after postoperative myocardial infarction in patients with coronary stents undergoing noncardiac surgery. Am J Surg. 2016 Nov; 212(5):814-822.e1.
Score: 0.018
-
Shafiq A, Valle J, Jang JS, Qintar M, Gosch K, Cohen DJ, Singh M, Bach R, Spertus JA. Variation in Practice Regarding Pretreatment With Dual Antiplatelet Therapy for Patients With Non-ST Elevation Myocardial Infarction. J Am Heart Assoc. 2016 06 10; 5(6).
Score: 0.018
-
Gurm HS, Valle JA, Smith DE, Ellis SG. Eroding the denominator: the incomplete story of door-to-balloon time reporting. J Am Coll Cardiol. 2012 Aug 21; 60(8):789-90.
Score: 0.014
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|